circRNA basic information
circBase ID: hsa_circ_0001944
Name: -
Synonym: circ_0001944
Host Gene: -
Genomic location(hg19): chrX:130883333-130928494:-
Genomic location(hg38): chrX:131749305-131794466:-
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

tumor

Cell lines:

Huh7; SMMC7721; Huh7/SOR; SMMC7721/SOR

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: FBLN2
Associated microRNA: miR-1292-5p
Biological function: promotes sorafenib resistance and suppresses ferroptosis in HCC cells
Molecular mechanism: circ_0001944 sponges/targets miR-1292-5p, relieving repression of FBLN2 and thereby rearranging iron homeostasis and lipid peroxidation to inhibit ferroptosis, leading to sorafenib resistance
Biological pathway or process:

ferroptosis (inhibits); drug resistance (promotes); ceRNA regulation (other)

Detected method:
Q
S
Validation methods:

circRNA-seq; RT-qPCR; Bioinformatics Analysis; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; Western Blot; In Vivo Animal Model

Clinical significance:

Circ_0001944 is a putative target for reversing sorafenib resistance in HCC.

Description:

In sorafenib-resistant HCC cells, circ_0001944 is up-regulated and promotes sorafenib resistance. It directly targets miR-1292-5p to regulate the miR-1292-5p/FBLN2 axis, leading to suppression of ferroptosis (reduced iron overload/ROS/lipid peroxidation).

Confidence score:

0.7164

Other information
Title:

Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis.

Journal: ImmunoTargets and therapy
Published: 2024
PubMed ID: 39624827
Study type:

combined biological and clinical study

Data availability: The data used to support the findings of this study are available from the corresponding author upon request.
Code availability: -